3Carey RM,Siragy HM.Newly recognized components of the reninangiotensin system:potential roles in cardiovascular and renal regulation.Endocrine Rev,2003,24:261-271.
4Brewster UC,Perazella MA.The renin.angiotensin-aldosterone system and the kidney:effects on kidney disease.Am J Med,2004,116:263-272.
5Li Y,Hashim S,Anand-Srivastava MB.Intraeellular peptides of natriuretic pepfide receptor-C inhibit vascular hypertrophy via Gqalpha/MAP kinase siguulins pathways.Cardiovasc Res,2006,72:464-472.
7Meyer LH,Backer A,Klamer HJ.Inhibitors of Na^+-K^+-ATPase in human urine:effects of ouabain-like factors and of vanadiumdiascorbate on calcium mobilization in rat vasc-ar smooth muscle cells:comparison with the effects of ouabain,angiotensin Ⅱ,and arginine-vasopressim Am J Hypertens,2000,13:364-369.
8Chen KH,Chen SJ,Wu CC.Regulation of Na+K+ATPasein rat aortas:pharmacoogical and functional evidence.Chin J Physiol,2005,48:86-92.
9William M,Vien J,Hamilton E,et al.The nitric Oxide donor sodium nitropmsside stimulates the Na-K pump in isolaed rabbit cardiac myocytes.J Physiol,2005,565:815-825.
